| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | See Remarks
2 companies
Ng George K is a See Remarks at Sorrento Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 7 buys and 1 sell.
Estimated insider holdings value: $238K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 87,200 | $0.80 | $69,542.00 | New | -61.5% | -79.1% | |
| Jan 30, 2024 | PCSA Processa Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 10,000 | $2.70 | $27,000.00 | +100.0% | -22.2% | -78.1% | |
| Feb 28, 2018 | SRNE Sorrento Therapeutics, Inc. | See Remarks | Buy | 90,000 | $9.95 | $895,500.00 | +785.8% | - | - | |
| Feb 3, 2017 | SRNE Sorrento Therapeutics, Inc. | See Remarks | Sell | 40,000 | $5.15 | $206,000.00 | -44.8% | - | - | |
| Aug 21, 2015 | SRNE Sorrento Therapeutics, Inc. | See Remarks | Buy | 888 | $13.50 | $11,989.52 | +66.6% | - | - | |
| Aug 3, 2015 | SRNE Sorrento Therapeutics, Inc. | See Remarks | Buy | 11,453 | $11.50 | $131,709.50 | +332.2% | - | - |